Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Ekso Bionics Holdings (EKSO) over the last 12 years, with Q3 2025 value amounting to $12000.0.

  • Ekso Bionics Holdings' Capital Expenditures rose 5000.0% to $12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $83000.0, marking a year-over-year increase of 4067.8%. This contributed to the annual value of $37000.0 for FY2024, which is 7643.31% down from last year.
  • Per Ekso Bionics Holdings' latest filing, its Capital Expenditures stood at $12000.0 for Q3 2025, which was up 5000.0% from $40000.0 recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Capital Expenditures peaked at $141000.0 during Q3 2022, and registered a low of -$1000.0 during Q4 2021.
  • Moreover, its 5-year median value for Capital Expenditures was $21000.0 (2024), whereas its average is $34538.5.
  • As far as peak fluctuations go, Ekso Bionics Holdings' Capital Expenditures soared by 540000.0% in 2022, and later plummeted by 8794.33% in 2023.
  • Ekso Bionics Holdings' Capital Expenditures (Quarter) stood at -$1000.0 in 2021, then soared by 5400.0% to $53000.0 in 2022, then decreased by 18.87% to $43000.0 in 2023, then crashed by 51.16% to $21000.0 in 2024, then tumbled by 42.86% to $12000.0 in 2025.
  • Its Capital Expenditures was $12000.0 in Q3 2025, compared to $40000.0 in Q2 2025 and $10000.0 in Q1 2025.